Musings from The Power List: Miguel Forte

• by Miguel Forte

• September 8, 2026

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

• by Arnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard, Depei Wu, Erlie Jiang, Nathalie Dhedin, Anne Sirvent, Jan Vydra, Jakob Passweg, Bruno Lioure, Jaime Sanz, Jurjen Versluis, Yajing Xu, Cristina Castilla-Llorente, Rodrigo Martino Bufarull, Victoria Potter, Nour Ben Abdeljelil, Eolia Brissot, Ali Bazarbachi, Bipin Savani, Sebastian Giebel, Mohamad Mohty, Fabio Ciceri

• August 31, 2026

Evidence of nosocomial human-to-human transmission of Dabie bandavirus: a clinical, epidemiological, and virological investigation

• by Shan Hong, Kai Li, Jingqi Yang, Xianfang Peng, Tianshu Cao, Yufei Xie, Yongqiang Deng, Mengxu Sun, Qi Chen, Xiang Chen, Aiping Wu, Hangyu Zhou, Shengjun Wu, Xingyao Huang, Chengfeng Qin

• August 31, 2026

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

• August 31, 2026

• 5 min